Back
Corcept Therapeutics Stock Predictions
BigBear.ai stock just exploded on AI and big data plays, surging to a $2B valuation.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
71
CORT
Corcept Therapeutics
Last Price:
$60.62
Seasonality Move:
8.24%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Corcept Therapeutics Stock Forecast
-
Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 34.3% based on the past 20 years of stock performance.
-
Corcept Therapeutics has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
-
Is Corcept Therapeutics Stock Undervalued?The current Corcept Therapeutics [CORT] share price is $59.85. The Score for CORT is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 34.3% based on the past 20 years of stock performance.
Corcept Therapeutics Stock Rating
Buy
71
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics overpriced?
-
Corcept Therapeutics has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
Corcept Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
75.00
52-Week Low:
20.84
Prediction Charts
Market Cap:
6.3B
Price in USD:
59.85
Volume:
2.1M
Beta:
0.89
Technical Analysis
SMA50:
59.40
SMA100:
55.89
SMA200:
44.72
52-Wk Change:
147.83%
Stock Predictions
-
Is Corcept Therapeutics stock public?Yes, Corcept Therapeutics is a publicly traded company.
-
What is the Corcept Therapeutics stock quote today?The Corcept Therapeutics stock price is 59.85 USD today.
-
How to buy Corcept Therapeutics stock online?You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-6 | 68.11 | 68.04 | 69.40 | 67.41 |
| Feb-7 | 68.06 | 68.01 | 70.01 | 67.17 |
| Feb-10 | 68.08 | 67.54 | 68.66 | 67.34 |
| Feb-11 | 67.92 | 68.11 | 70.27 | 67.77 |
| Feb-12 | 66.62 | 70.15 | 70.68 | 66.28 |
| Feb-13 | 70.13 | 73.61 | 73.75 | 69.55 |
| Feb-14 | 74.00 | 72.72 | 74.61 | 72.00 |
| Feb-18 | 73.63 | 72.60 | 74.50 | 71.50 |
| Feb-19 | 73.85 | 73.53 | 75.00 | 71.52 |
| Feb-20 | 73.05 | 65.09 | 74.00 | 64.34 |
| Feb-21 | 65.90 | 63.48 | 66.48 | 63.19 |
| Feb-25 | 61.60 | 61.23 | 61.71 | 59.09 |
| Feb-26 | 61.61 | 63.37 | 64.25 | 61.59 |
| Feb-27 | 61.00 | 59.85 | 64.66 | 59.25 |
Corcept Therapeutics Earnings
Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics Forecast Revenue Growth
Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.05 per share, an increase this year of $0.33 per share, and an increase next year of $2.32 per share.
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.